BioMedInvest II is a closed private equity fund managed by BioMed Partners.
ImevaX, a German biotech firm focused on vaccines for chronic infectious diseases, has raised €7.5m led by Wellington Partners.
Germany-based pharmaceutical firm Activaero has raised €130m for its PE backers in a trade sale to Vectura Group.
Read more news concerning BioMedInvest II
BioMed Partners is a private equity general partner firm headquartered in Basel, Switzerland.
View full profile
Registration is fast, free and easy
Already a member?